Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
GLOBETECH PUBLISHING
JIB

New Line of Small Benchtop Centrifuges Minimizes Space Requirement While Maximizing Flexibility

By BiotechDaily International staff writers
Posted on 06 Jun 2013
 Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
A new line of benchtop centrifuges was designed to provide exceptional capacity in a compact design with a smart, simple interface and the flexibility to support both clinical and research applications.

Sale of the new instrument was recently launched by Thermo Fisher Scientific Inc. (Milford, MA, USA). The new line of centrifuges is highlighted by a particularly compact footprint, which conserves valuable laboratory bench space. Nonetheless, the instrument can accommodate eight 50 mL tubes, four microplates, or 30 filtration columns in a swinging bucket rotor. The "Auto-Lock" rotor exchange enables rotor replacement in less than three seconds while delivering trouble-free rotor installation and removal and clear chamber access for cleaning convenience.

The centrifuges are manufactured with quality materials providing broad chemical resistance with exceptional strength for durability and reliability. The instrument is controlled via an intuitive glove and detergent friendly interface with a bright backlit display, featuring one-touch operation with preset protocol options and optional password protection.

“Centrifuges are critical laboratory resources that are in constant use and demand. It is crucial to avoid bottlenecks in these lab workflows that could create unwanted downtime and negatively impact users’ work,” said Maurizio Merli, product director at Thermo Fisher Scientific. “With features designed to optimize simplicity, safety, and flexibility, the new Thermo Scientific small benchtop centrifuges can help scientists save time and maximize resources in busy labs and clinics.”

Related Links:
Thermo Fisher Scientific Inc.




comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.